Clinical trial
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
NCT04874038 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- September 22, 2021
- Completion date
- May 1, 2027
- Enrollment
- 1,604 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, pain, chronic, pain, postoperative, post-mastectomy pain syndrome